4//SEC Filing
Rothfuss Cristin 4
Accession 0000950170-25-037527
CIK 0000873303other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 8:00 PM ET
Size
9.0 KB
Accession
0000950170-25-037527
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Tax Payment
Common Stock
2025-03-10$100.13/sh−491$49,164→ 12,834 total - Award
Common Stock
2025-03-10+8,276→ 21,110 total - Award
Stock Options (right to buy)
2025-03-10+16,644→ 16,644 totalExercise: $99.69From: 2026-03-10Exp: 2035-03-10→ Common Stock (16,644 underlying)
Footnotes (3)
- [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.
- [F2]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
- [F3]Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0002046214
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 8:00 PM ET
- Size
- 9.0 KB